Intervention

Treatment interruption

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions5

Lead sponsors shown4

Clinical trials

4 shown

Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV InfectionNCT02614950 · 2016-02-01

Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral TxNCT00071890 · 2003-10-01

Long-Term Supervised Treatment Interruption in HIV-Infected PatientsNCT00118677 · 2003-02-01

Staccato: A Trial of CD4 Guided Treatment Interruption, Compared to Continuous Treatment, for HIV InfectionNCT00113126 · 2002-01-01

Common conditions

HIV Infections2 Acute HIV Infection1 AIDS1 Antiretroviral Treatment Interruption1 HIV Infection1

Leading sponsors

French National Agency for Research on AIDS and Viral Hepatitis1 National Institute of Allergy and Infectious Diseases (NIAID)1 SEARCH Research Foundation1 University Hospital, Geneva1

Trial status mix

COMPLETED4

Phase mix

NA2

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.